The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
InterAACT: An international multicenter open label randomized phase II advanced anal cancer trial comparing cisplatin (CDDP) plus 5-fluorouracil (5-FU) versus carboplatin (CBDCA) plus weekly paclitaxel (PTX) in patients with inoperable locally recurrent (ILR) or metastatic disease.
 
Francesco Sclafani
No Relationships to Disclose
 
Richard A. Adams
No Relationships to Disclose
 
Cathy Eng
Honoraria - Roche; Sanofi
Consulting or Advisory Role - Bayer Schering Pharma; Roche/Genentech; Sanofi
Research Funding - ArQule; Keryx
Travel, Accommodations, Expenses - Genentech/Roche; Sanofi
 
Al Bowen Benson
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech/Roche; Lilly/ImClone; Merck Serono; Merck/Schering Plough; Sanofi; Spectrum Pharmaceuticals
Research Funding - advanced accelerator applications; Amgen; Astellas Pharma; Bayer/Onyx; Genentech (I); Gilead Sciences; Novartis
Travel, Accommodations, Expenses - Bayer; Genentech/Roche; Lilly/ImClone; Sanofi; Spectrum Pharmaceuticals
 
Robert Glynne-Jones
No Relationships to Disclose
 
David Sebag-Montefiore
No Relationships to Disclose
 
Dirk Arnold
No Relationships to Disclose
 
Amitesh Chandra Roy
No Relationships to Disclose
 
Marianne Grønlie Guren
No Relationships to Disclose
 
Eva Segelov
No Relationships to Disclose
 
Matthew T. Seymour
No Relationships to Disclose
 
Annette Bryant
No Relationships to Disclose
 
Clare Peckitt
No Relationships to Disclose
 
David Cunningham
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); MedImmune (Inst); Merck Serono (Inst); Merrimack (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)
 
John A. Bridgewater
No Relationships to Disclose
 
Jack Welch
No Relationships to Disclose
 
Peter J. O'Dwyer
No Relationships to Disclose
 
Elisabeth Dupont
No Relationships to Disclose
 
Andrea McConnell
No Relationships to Disclose
 
Sheela Rao
No Relationships to Disclose